Latest Attention-deficit hyperactivity disorder Stories
Attention Point® is pleased to announce the “Weiss ADHD Comorbid Screen” (WACS) and the “Teacher Report of School Function”, both developed by Dr.
Two recent studies reveal that child abuse is much more common in ADHD and dyslexia. In Dr.
The European Biostimulants Market report defines and segments the biostimulants market in Europe with analysis and forecast of revenue.
STAR (Sensory Therapies And Research) Center, the premier treatment center for children with sensory challenges launches two new programs for children who would benefit from therapeutic activities
LEXINGTON, Massachusetts, July 17, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) today announced top-line results from two Phase 4 efficacy and safety studies
Cumberland Academy of Georgia was recently included in an article assembling the 50 best private schools for students with special needs across the United States.
The inability to ignore irrelevant stimuli underlies the impaired working memory and cognition often experienced by individuals diagnosed with schizophrenia.
South Burlington’s Dr.
Over the last 60 years, the U.S. Food and Drug Administration (FDA) approved 20 medications for attention deficit/hyperactivity disorder (ADHD) based on clinical trials that were not designed to study their long-term efficacy and safety or to detect rare adverse events.
Study calls for more focus on long-term outcomes in pediatric trials of drugs intended for chronic use BOSTON, July 9, 2014 /PRNewswire-USNewswire/ -- Over the last 60 years, the U.S.
- A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.